Clinical Trial Update: A Clinical Trial to Evaluate the Safety of agenT-797 in COVID-19 Participants With ARDS [Phase 1]

View source ↗

Summary

This update summarizes the safety results from a Phase 1 trial evaluating agenT-797 in adults with COVID-19-related acute respiratory distress syndrome (ARDS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• agenT-797 (agenT-797)

Snippet

Sponsor: MiNK Therapeutics | Conditions: Respiratory Distress Syndrome, Adult | Phase 1 | Status: COMPLETED